nodes	percent_of_prediction	percent_of_DWPC	metapath
Neomycin—Framycetin—CXCR4—hematologic cancer	0.0251	1	CrCbGaD
Neomycin—Hypersensitivity—Idarubicin—hematologic cancer	0.00148	0.00152	CcSEcCtD
Neomycin—Viral infection—Epirubicin—hematologic cancer	0.00148	0.00152	CcSEcCtD
Neomycin—Pruritus—Anagrelide—hematologic cancer	0.00147	0.00151	CcSEcCtD
Neomycin—Pruritus—Pentostatin—hematologic cancer	0.00147	0.00151	CcSEcCtD
Neomycin—Diarrhoea—Mercaptopurine—hematologic cancer	0.00145	0.00149	CcSEcCtD
Neomycin—Erythema—Thiotepa—hematologic cancer	0.00145	0.00149	CcSEcCtD
Neomycin—Hypersensitivity—Teniposide—hematologic cancer	0.00144	0.00148	CcSEcCtD
Neomycin—Diarrhoea—Clofarabine—hematologic cancer	0.00143	0.00147	CcSEcCtD
Neomycin—Diarrhoea—Daunorubicin—hematologic cancer	0.00143	0.00147	CcSEcCtD
Neomycin—Diarrhoea—Pentostatin—hematologic cancer	0.00142	0.00146	CcSEcCtD
Neomycin—Diarrhoea—Anagrelide—hematologic cancer	0.00142	0.00146	CcSEcCtD
Neomycin—Vomiting—Nelarabine—hematologic cancer	0.00142	0.00146	CcSEcCtD
Neomycin—Anaphylactic shock—Melphalan—hematologic cancer	0.00142	0.00145	CcSEcCtD
Neomycin—Infection—Melphalan—hematologic cancer	0.00141	0.00144	CcSEcCtD
Neomycin—Pruritus—Teniposide—hematologic cancer	0.00138	0.00142	CcSEcCtD
Neomycin—Diarrhoea—Idarubicin—hematologic cancer	0.00137	0.00141	CcSEcCtD
Neomycin—Infection—Lenalidomide—hematologic cancer	0.00137	0.0014	CcSEcCtD
Neomycin—Viral infection—Doxorubicin—hematologic cancer	0.00137	0.0014	CcSEcCtD
Neomycin—Infection—Hydroxyurea—hematologic cancer	0.00135	0.00138	CcSEcCtD
Neomycin—Vomiting—Mercaptopurine—hematologic cancer	0.00135	0.00138	CcSEcCtD
Neomycin—Erythema—Carmustine—hematologic cancer	0.00135	0.00138	CcSEcCtD
Neomycin—Diarrhoea—Teniposide—hematologic cancer	0.00134	0.00137	CcSEcCtD
Neomycin—Hypersensitivity—Busulfan—hematologic cancer	0.00133	0.00137	CcSEcCtD
Neomycin—Erythema—Alitretinoin—hematologic cancer	0.00133	0.00137	CcSEcCtD
Neomycin—Vomiting—Daunorubicin—hematologic cancer	0.00133	0.00136	CcSEcCtD
Neomycin—Vomiting—Clofarabine—hematologic cancer	0.00133	0.00136	CcSEcCtD
Neomycin—Nausea—Nelarabine—hematologic cancer	0.00133	0.00136	CcSEcCtD
Neomycin—Vomiting—Anagrelide—hematologic cancer	0.00132	0.00136	CcSEcCtD
Neomycin—Vomiting—Pentostatin—hematologic cancer	0.00132	0.00136	CcSEcCtD
Neomycin—Erythema—Ifosfamide—hematologic cancer	0.00132	0.00135	CcSEcCtD
Neomycin—Nausea—Methoxsalen—hematologic cancer	0.0013	0.00133	CcSEcCtD
Neomycin—Hypersensitivity—Procarbazine—hematologic cancer	0.00129	0.00133	CcSEcCtD
Neomycin—Pruritus—Busulfan—hematologic cancer	0.00128	0.00131	CcSEcCtD
Neomycin—Vomiting—Idarubicin—hematologic cancer	0.00128	0.00131	CcSEcCtD
Neomycin—Anaphylactic shock—Bortezomib—hematologic cancer	0.00127	0.0013	CcSEcCtD
Neomycin—Hypersensitivity—Bexarotene—hematologic cancer	0.00127	0.0013	CcSEcCtD
Neomycin—Hypersensitivity—Dasatinib—hematologic cancer	0.00127	0.0013	CcSEcCtD
Neomycin—Hypersensitivity—Fludarabine—hematologic cancer	0.00126	0.0013	CcSEcCtD
Neomycin—Infection—Bortezomib—hematologic cancer	0.00126	0.00129	CcSEcCtD
Neomycin—Nausea—Mercaptopurine—hematologic cancer	0.00126	0.00129	CcSEcCtD
Neomycin—Anaphylactic shock—Bleomycin—hematologic cancer	0.00126	0.00129	CcSEcCtD
Neomycin—Erythema—Mitoxantrone—hematologic cancer	0.00125	0.00128	CcSEcCtD
Neomycin—Infection—Bleomycin—hematologic cancer	0.00125	0.00128	CcSEcCtD
Neomycin—Pruritus—Procarbazine—hematologic cancer	0.00124	0.00127	CcSEcCtD
Neomycin—Nausea—Clofarabine—hematologic cancer	0.00124	0.00127	CcSEcCtD
Neomycin—Nausea—Daunorubicin—hematologic cancer	0.00124	0.00127	CcSEcCtD
Neomycin—Vomiting—Teniposide—hematologic cancer	0.00124	0.00127	CcSEcCtD
Neomycin—Diarrhoea—Busulfan—hematologic cancer	0.00124	0.00127	CcSEcCtD
Neomycin—Anaphylactic shock—Vinorelbine—hematologic cancer	0.00124	0.00127	CcSEcCtD
Neomycin—Nausea—Pentostatin—hematologic cancer	0.00124	0.00127	CcSEcCtD
Neomycin—Nausea—Anagrelide—hematologic cancer	0.00124	0.00127	CcSEcCtD
Neomycin—Infection—Vinorelbine—hematologic cancer	0.00123	0.00126	CcSEcCtD
Neomycin—Erythema—Gemcitabine—hematologic cancer	0.00122	0.00125	CcSEcCtD
Neomycin—Pruritus—Bexarotene—hematologic cancer	0.00122	0.00125	CcSEcCtD
Neomycin—Pruritus—Dasatinib—hematologic cancer	0.00122	0.00125	CcSEcCtD
Neomycin—Pruritus—Fludarabine—hematologic cancer	0.00121	0.00125	CcSEcCtD
Neomycin—Diarrhoea—Procarbazine—hematologic cancer	0.0012	0.00123	CcSEcCtD
Neomycin—Hypersensitivity—Chlorambucil—hematologic cancer	0.0012	0.00123	CcSEcCtD
Neomycin—Nausea—Idarubicin—hematologic cancer	0.00119	0.00122	CcSEcCtD
Neomycin—Diarrhoea—Dasatinib—hematologic cancer	0.00118	0.00121	CcSEcCtD
Neomycin—Diarrhoea—Bexarotene—hematologic cancer	0.00118	0.00121	CcSEcCtD
Neomycin—Infection—Thiotepa—hematologic cancer	0.00117	0.0012	CcSEcCtD
Neomycin—Diarrhoea—Fludarabine—hematologic cancer	0.00117	0.0012	CcSEcCtD
Neomycin—Hypersensitivity—Nilotinib—hematologic cancer	0.00117	0.0012	CcSEcCtD
Neomycin—Hypersensitivity—Imatinib—hematologic cancer	0.00116	0.00119	CcSEcCtD
Neomycin—Nausea—Teniposide—hematologic cancer	0.00116	0.00119	CcSEcCtD
Neomycin—Vomiting—Busulfan—hematologic cancer	0.00115	0.00118	CcSEcCtD
Neomycin—Pruritus—Chlorambucil—hematologic cancer	0.00115	0.00118	CcSEcCtD
Neomycin—Hypersensitivity—Cladribine—hematologic cancer	0.00114	0.00117	CcSEcCtD
Neomycin—Infection—Thalidomide—hematologic cancer	0.00114	0.00117	CcSEcCtD
Neomycin—Erythema—Cisplatin—hematologic cancer	0.00114	0.00117	CcSEcCtD
Neomycin—Pruritus—Nilotinib—hematologic cancer	0.00112	0.00115	CcSEcCtD
Neomycin—Pruritus—Imatinib—hematologic cancer	0.00112	0.00115	CcSEcCtD
Neomycin—Vomiting—Procarbazine—hematologic cancer	0.00112	0.00114	CcSEcCtD
Neomycin—Diarrhoea—Chlorambucil—hematologic cancer	0.00111	0.00114	CcSEcCtD
Neomycin—Pruritus—Cladribine—hematologic cancer	0.0011	0.00113	CcSEcCtD
Neomycin—Hypersensitivity—Vinblastine—hematologic cancer	0.0011	0.00113	CcSEcCtD
Neomycin—Vomiting—Bexarotene—hematologic cancer	0.00109	0.00112	CcSEcCtD
Neomycin—Vomiting—Dasatinib—hematologic cancer	0.00109	0.00112	CcSEcCtD
Neomycin—Infection—Carmustine—hematologic cancer	0.00109	0.00112	CcSEcCtD
Neomycin—Vomiting—Fludarabine—hematologic cancer	0.00109	0.00112	CcSEcCtD
Neomycin—Anaphylactic shock—Alitretinoin—hematologic cancer	0.00109	0.00112	CcSEcCtD
Neomycin—Diarrhoea—Nilotinib—hematologic cancer	0.00109	0.00112	CcSEcCtD
Neomycin—Diarrhoea—Imatinib—hematologic cancer	0.00108	0.00111	CcSEcCtD
Neomycin—Infection—Alitretinoin—hematologic cancer	0.00108	0.00111	CcSEcCtD
Neomycin—Anaphylactic shock—Ifosfamide—hematologic cancer	0.00108	0.0011	CcSEcCtD
Neomycin—Nausea—Busulfan—hematologic cancer	0.00107	0.0011	CcSEcCtD
Neomycin—Infection—Ifosfamide—hematologic cancer	0.00107	0.0011	CcSEcCtD
Neomycin—Diarrhoea—Cladribine—hematologic cancer	0.00106	0.00109	CcSEcCtD
Neomycin—Anaphylactic shock—Vincristine—hematologic cancer	0.00105	0.00108	CcSEcCtD
Neomycin—Hypersensitivity—Melphalan—hematologic cancer	0.00104	0.00107	CcSEcCtD
Neomycin—Nausea—Procarbazine—hematologic cancer	0.00104	0.00107	CcSEcCtD
Neomycin—Infection—Vincristine—hematologic cancer	0.00104	0.00107	CcSEcCtD
Neomycin—Vomiting—Chlorambucil—hematologic cancer	0.00103	0.00106	CcSEcCtD
Neomycin—Erythema—Prednisolone—hematologic cancer	0.00103	0.00105	CcSEcCtD
Neomycin—Nausea—Bexarotene—hematologic cancer	0.00102	0.00105	CcSEcCtD
Neomycin—Nausea—Dasatinib—hematologic cancer	0.00102	0.00105	CcSEcCtD
Neomycin—Anaphylactic shock—Mitoxantrone—hematologic cancer	0.00102	0.00105	CcSEcCtD
Neomycin—Anaphylactic shock—Irinotecan—hematologic cancer	0.00102	0.00105	CcSEcCtD
Neomycin—Nausea—Fludarabine—hematologic cancer	0.00102	0.00105	CcSEcCtD
Neomycin—Diarrhoea—Vinblastine—hematologic cancer	0.00102	0.00105	CcSEcCtD
Neomycin—Hypersensitivity—Lenalidomide—hematologic cancer	0.00102	0.00104	CcSEcCtD
Neomycin—Infection—Irinotecan—hematologic cancer	0.00101	0.00104	CcSEcCtD
Neomycin—Infection—Mitoxantrone—hematologic cancer	0.00101	0.00104	CcSEcCtD
Neomycin—Vomiting—Nilotinib—hematologic cancer	0.00101	0.00104	CcSEcCtD
Neomycin—Vomiting—Imatinib—hematologic cancer	0.00101	0.00103	CcSEcCtD
Neomycin—Pruritus—Melphalan—hematologic cancer	0.001	0.00103	CcSEcCtD
Neomycin—Hypersensitivity—Hydroxyurea—hematologic cancer	0.001	0.00103	CcSEcCtD
Neomycin—Anaphylactic shock—Gemcitabine—hematologic cancer	0.000995	0.00102	CcSEcCtD
Neomycin—Infection—Gemcitabine—hematologic cancer	0.000988	0.00101	CcSEcCtD
Neomycin—Vomiting—Cladribine—hematologic cancer	0.000988	0.00101	CcSEcCtD
Neomycin—Pruritus—Lenalidomide—hematologic cancer	0.000975	0.001	CcSEcCtD
Neomycin—Diarrhoea—Melphalan—hematologic cancer	0.00097	0.000994	CcSEcCtD
Neomycin—Nausea—Chlorambucil—hematologic cancer	0.000966	0.00099	CcSEcCtD
Neomycin—Vomiting—Vinblastine—hematologic cancer	0.000947	0.000972	CcSEcCtD
Neomycin—Nausea—Nilotinib—hematologic cancer	0.000944	0.000969	CcSEcCtD
Neomycin—Erythema—Triamcinolone—hematologic cancer	0.000944	0.000968	CcSEcCtD
Neomycin—Diarrhoea—Lenalidomide—hematologic cancer	0.000943	0.000967	CcSEcCtD
Neomycin—Nausea—Imatinib—hematologic cancer	0.000939	0.000963	CcSEcCtD
Neomycin—Hypersensitivity—Bortezomib—hematologic cancer	0.000934	0.000958	CcSEcCtD
Neomycin—Diarrhoea—Hydroxyurea—hematologic cancer	0.00093	0.000953	CcSEcCtD
Neomycin—Anaphylactic shock—Cisplatin—hematologic cancer	0.000927	0.000951	CcSEcCtD
Neomycin—Hypersensitivity—Bleomycin—hematologic cancer	0.000927	0.000951	CcSEcCtD
Neomycin—Nausea—Cladribine—hematologic cancer	0.000923	0.000946	CcSEcCtD
Neomycin—Infection—Cisplatin—hematologic cancer	0.000921	0.000945	CcSEcCtD
Neomycin—Hypersensitivity—Vinorelbine—hematologic cancer	0.000912	0.000936	CcSEcCtD
Neomycin—Vomiting—Melphalan—hematologic cancer	0.000901	0.000924	CcSEcCtD
Neomycin—Pruritus—Bortezomib—hematologic cancer	0.000897	0.00092	CcSEcCtD
Neomycin—Pruritus—Bleomycin—hematologic cancer	0.00089	0.000913	CcSEcCtD
Neomycin—Nausea—Vinblastine—hematologic cancer	0.000885	0.000908	CcSEcCtD
Neomycin—Vomiting—Lenalidomide—hematologic cancer	0.000876	0.000899	CcSEcCtD
Neomycin—Pruritus—Vinorelbine—hematologic cancer	0.000876	0.000898	CcSEcCtD
Neomycin—Hypersensitivity—Thiotepa—hematologic cancer	0.000871	0.000893	CcSEcCtD
Neomycin—Diarrhoea—Bortezomib—hematologic cancer	0.000867	0.00089	CcSEcCtD
Neomycin—Vomiting—Hydroxyurea—hematologic cancer	0.000864	0.000886	CcSEcCtD
Neomycin—Erythema—Dexamethasone—hematologic cancer	0.000856	0.000878	CcSEcCtD
Neomycin—Erythema—Betamethasone—hematologic cancer	0.000856	0.000878	CcSEcCtD
Neomycin—Anaphylactic shock—Etoposide—hematologic cancer	0.000849	0.000871	CcSEcCtD
Neomycin—Diarrhoea—Vinorelbine—hematologic cancer	0.000847	0.000869	CcSEcCtD
Neomycin—Infection—Etoposide—hematologic cancer	0.000844	0.000865	CcSEcCtD
Neomycin—Hypersensitivity—Thalidomide—hematologic cancer	0.000842	0.000864	CcSEcCtD
Neomycin—Nausea—Melphalan—hematologic cancer	0.000842	0.000863	CcSEcCtD
Neomycin—Anaphylactic shock—Prednisolone—hematologic cancer	0.000838	0.000859	CcSEcCtD
Neomycin—Pruritus—Thiotepa—hematologic cancer	0.000836	0.000858	CcSEcCtD
Neomycin—Nausea—Lenalidomide—hematologic cancer	0.000818	0.000839	CcSEcCtD
Neomycin—Hypersensitivity—Carmustine—hematologic cancer	0.000809	0.00083	CcSEcCtD
Neomycin—Pruritus—Thalidomide—hematologic cancer	0.000809	0.00083	CcSEcCtD
Neomycin—Diarrhoea—Thiotepa—hematologic cancer	0.000809	0.00083	CcSEcCtD
Neomycin—Nausea—Hydroxyurea—hematologic cancer	0.000807	0.000828	CcSEcCtD
Neomycin—Vomiting—Bortezomib—hematologic cancer	0.000806	0.000827	CcSEcCtD
Neomycin—Hypersensitivity—Alitretinoin—hematologic cancer	0.000802	0.000822	CcSEcCtD
Neomycin—Vomiting—Bleomycin—hematologic cancer	0.0008	0.000821	CcSEcCtD
Neomycin—Hypersensitivity—Ifosfamide—hematologic cancer	0.000792	0.000813	CcSEcCtD
Neomycin—Vomiting—Vinorelbine—hematologic cancer	0.000787	0.000807	CcSEcCtD
Neomycin—Diarrhoea—Thalidomide—hematologic cancer	0.000782	0.000803	CcSEcCtD
Neomycin—Hypersensitivity—Vincristine—hematologic cancer	0.000772	0.000792	CcSEcCtD
Neomycin—Anaphylactic shock—Triamcinolone—hematologic cancer	0.00077	0.00079	CcSEcCtD
Neomycin—Pruritus—Alitretinoin—hematologic cancer	0.00077	0.00079	CcSEcCtD
Neomycin—Infection—Triamcinolone—hematologic cancer	0.000765	0.000785	CcSEcCtD
Neomycin—Pruritus—Ifosfamide—hematologic cancer	0.000761	0.00078	CcSEcCtD
Neomycin—Nausea—Bortezomib—hematologic cancer	0.000753	0.000772	CcSEcCtD
Neomycin—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000752	0.000772	CcSEcCtD
Neomycin—Hypersensitivity—Irinotecan—hematologic cancer	0.000752	0.000772	CcSEcCtD
Neomycin—Vomiting—Thiotepa—hematologic cancer	0.000752	0.000771	CcSEcCtD
Neomycin—Diarrhoea—Carmustine—hematologic cancer	0.000751	0.000771	CcSEcCtD
Neomycin—Nausea—Bleomycin—hematologic cancer	0.000747	0.000767	CcSEcCtD
Neomycin—Erythema—Prednisone—hematologic cancer	0.000746	0.000765	CcSEcCtD
Neomycin—Diarrhoea—Alitretinoin—hematologic cancer	0.000744	0.000764	CcSEcCtD
Neomycin—Diarrhoea—Ifosfamide—hematologic cancer	0.000736	0.000755	CcSEcCtD
Neomycin—Nausea—Vinorelbine—hematologic cancer	0.000735	0.000754	CcSEcCtD
Neomycin—Vomiting—Thalidomide—hematologic cancer	0.000727	0.000746	CcSEcCtD
Neomycin—Diarrhoea—Vincristine—hematologic cancer	0.000717	0.000736	CcSEcCtD
Neomycin—Pruritus—Gemcitabine—hematologic cancer	0.000704	0.000722	CcSEcCtD
Neomycin—Nausea—Thiotepa—hematologic cancer	0.000702	0.00072	CcSEcCtD
Neomycin—Anaphylactic shock—Betamethasone—hematologic cancer	0.000699	0.000717	CcSEcCtD
Neomycin—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000699	0.000717	CcSEcCtD
Neomycin—Diarrhoea—Mitoxantrone—hematologic cancer	0.000699	0.000717	CcSEcCtD
Neomycin—Diarrhoea—Irinotecan—hematologic cancer	0.000699	0.000717	CcSEcCtD
Neomycin—Vomiting—Carmustine—hematologic cancer	0.000698	0.000716	CcSEcCtD
Neomycin—Infection—Betamethasone—hematologic cancer	0.000694	0.000712	CcSEcCtD
Neomycin—Infection—Dexamethasone—hematologic cancer	0.000694	0.000712	CcSEcCtD
Neomycin—Vomiting—Alitretinoin—hematologic cancer	0.000692	0.00071	CcSEcCtD
Neomycin—Vomiting—Ifosfamide—hematologic cancer	0.000684	0.000701	CcSEcCtD
Neomycin—Hypersensitivity—Cisplatin—hematologic cancer	0.000683	0.000701	CcSEcCtD
Neomycin—Diarrhoea—Gemcitabine—hematologic cancer	0.00068	0.000698	CcSEcCtD
Neomycin—Nausea—Thalidomide—hematologic cancer	0.000679	0.000697	CcSEcCtD
Neomycin—Vomiting—Vincristine—hematologic cancer	0.000667	0.000684	CcSEcCtD
Neomycin—Nausea—Carmustine—hematologic cancer	0.000652	0.000669	CcSEcCtD
Neomycin—Vomiting—Irinotecan—hematologic cancer	0.000649	0.000666	CcSEcCtD
Neomycin—Vomiting—Mitoxantrone—hematologic cancer	0.000649	0.000666	CcSEcCtD
Neomycin—Nausea—Alitretinoin—hematologic cancer	0.000646	0.000663	CcSEcCtD
Neomycin—Nausea—Ifosfamide—hematologic cancer	0.000639	0.000655	CcSEcCtD
Neomycin—Diarrhoea—Cisplatin—hematologic cancer	0.000634	0.000651	CcSEcCtD
Neomycin—Vomiting—Gemcitabine—hematologic cancer	0.000632	0.000649	CcSEcCtD
Neomycin—Hypersensitivity—Etoposide—hematologic cancer	0.000626	0.000642	CcSEcCtD
Neomycin—Erythema—Methotrexate—hematologic cancer	0.000623	0.000639	CcSEcCtD
Neomycin—Nausea—Vincristine—hematologic cancer	0.000623	0.000639	CcSEcCtD
Neomycin—Hypersensitivity—Prednisolone—hematologic cancer	0.000617	0.000633	CcSEcCtD
Neomycin—Anaphylactic shock—Prednisone—hematologic cancer	0.000609	0.000624	CcSEcCtD
Neomycin—Nausea—Irinotecan—hematologic cancer	0.000606	0.000622	CcSEcCtD
Neomycin—Nausea—Mitoxantrone—hematologic cancer	0.000606	0.000622	CcSEcCtD
Neomycin—Infection—Prednisone—hematologic cancer	0.000605	0.00062	CcSEcCtD
Neomycin—Pruritus—Etoposide—hematologic cancer	0.000601	0.000616	CcSEcCtD
Neomycin—Nausea—Gemcitabine—hematologic cancer	0.000591	0.000606	CcSEcCtD
Neomycin—Vomiting—Cisplatin—hematologic cancer	0.000589	0.000605	CcSEcCtD
Neomycin—Erythema—Epirubicin—hematologic cancer	0.000583	0.000598	CcSEcCtD
Neomycin—Diarrhoea—Etoposide—hematologic cancer	0.000581	0.000596	CcSEcCtD
Neomycin—Hypersensitivity—Triamcinolone—hematologic cancer	0.000568	0.000582	CcSEcCtD
Neomycin—Nausea—Cisplatin—hematologic cancer	0.000551	0.000565	CcSEcCtD
Neomycin—Pruritus—Triamcinolone—hematologic cancer	0.000545	0.000559	CcSEcCtD
Neomycin—Vomiting—Etoposide—hematologic cancer	0.00054	0.000554	CcSEcCtD
Neomycin—Erythema—Doxorubicin—hematologic cancer	0.00054	0.000554	CcSEcCtD
Neomycin—Anaphylactic shock—Methotrexate—hematologic cancer	0.000509	0.000522	CcSEcCtD
Neomycin—Infection—Methotrexate—hematologic cancer	0.000505	0.000518	CcSEcCtD
Neomycin—Nausea—Etoposide—hematologic cancer	0.000504	0.000517	CcSEcCtD
Neomycin—Nausea—Prednisolone—hematologic cancer	0.000498	0.00051	CcSEcCtD
Neomycin—Pruritus—Dexamethasone—hematologic cancer	0.000494	0.000507	CcSEcCtD
Neomycin—Pruritus—Betamethasone—hematologic cancer	0.000494	0.000507	CcSEcCtD
Neomycin—Vomiting—Triamcinolone—hematologic cancer	0.00049	0.000502	CcSEcCtD
Neomycin—Diarrhoea—Dexamethasone—hematologic cancer	0.000478	0.000491	CcSEcCtD
Neomycin—Diarrhoea—Betamethasone—hematologic cancer	0.000478	0.000491	CcSEcCtD
Neomycin—Anaphylactic shock—Epirubicin—hematologic cancer	0.000476	0.000488	CcSEcCtD
Neomycin—Infection—Epirubicin—hematologic cancer	0.000473	0.000485	CcSEcCtD
Neomycin—Nausea—Triamcinolone—hematologic cancer	0.000458	0.000469	CcSEcCtD
Neomycin—Hypersensitivity—Prednisone—hematologic cancer	0.000448	0.00046	CcSEcCtD
Neomycin—Vomiting—Dexamethasone—hematologic cancer	0.000444	0.000456	CcSEcCtD
Neomycin—Vomiting—Betamethasone—hematologic cancer	0.000444	0.000456	CcSEcCtD
Neomycin—Anaphylactic shock—Doxorubicin—hematologic cancer	0.00044	0.000452	CcSEcCtD
Neomycin—Infection—Doxorubicin—hematologic cancer	0.000438	0.000449	CcSEcCtD
Neomycin—Pruritus—Prednisone—hematologic cancer	0.000431	0.000442	CcSEcCtD
Neomycin—Diarrhoea—Prednisone—hematologic cancer	0.000416	0.000427	CcSEcCtD
Neomycin—Nausea—Dexamethasone—hematologic cancer	0.000415	0.000426	CcSEcCtD
Neomycin—Nausea—Betamethasone—hematologic cancer	0.000415	0.000426	CcSEcCtD
Neomycin—Vomiting—Prednisone—hematologic cancer	0.000387	0.000397	CcSEcCtD
Neomycin—Hypersensitivity—Methotrexate—hematologic cancer	0.000375	0.000384	CcSEcCtD
Neomycin—Nausea—Prednisone—hematologic cancer	0.000362	0.000371	CcSEcCtD
Neomycin—Pruritus—Methotrexate—hematologic cancer	0.00036	0.000369	CcSEcCtD
Neomycin—Hypersensitivity—Epirubicin—hematologic cancer	0.000351	0.00036	CcSEcCtD
Neomycin—Diarrhoea—Methotrexate—hematologic cancer	0.000348	0.000357	CcSEcCtD
Neomycin—Pruritus—Epirubicin—hematologic cancer	0.000337	0.000345	CcSEcCtD
Neomycin—Diarrhoea—Epirubicin—hematologic cancer	0.000326	0.000334	CcSEcCtD
Neomycin—Hypersensitivity—Doxorubicin—hematologic cancer	0.000325	0.000333	CcSEcCtD
Neomycin—Vomiting—Methotrexate—hematologic cancer	0.000323	0.000332	CcSEcCtD
Neomycin—Pruritus—Doxorubicin—hematologic cancer	0.000312	0.00032	CcSEcCtD
Neomycin—Vomiting—Epirubicin—hematologic cancer	0.000303	0.00031	CcSEcCtD
Neomycin—Nausea—Methotrexate—hematologic cancer	0.000302	0.00031	CcSEcCtD
Neomycin—Diarrhoea—Doxorubicin—hematologic cancer	0.000301	0.000309	CcSEcCtD
Neomycin—Nausea—Epirubicin—hematologic cancer	0.000283	0.00029	CcSEcCtD
Neomycin—Vomiting—Doxorubicin—hematologic cancer	0.00028	0.000287	CcSEcCtD
Neomycin—Nausea—Doxorubicin—hematologic cancer	0.000262	0.000268	CcSEcCtD
